Screening

Open-angle glaucoma often progresses without symptoms, and undetected glaucoma is both prevalent and treatable, suggesting a potential role for screening.[47]​ Population screening for open-angle glaucoma is, however, not cost-effective, and no country has established a viable national screening program.[13][48]

Targeted screening of high-risk groups is recommended (e.g., older adults, people with a family history of glaucoma, and African-Americans and Hispanics).[12]​ Relatives should also be examined.

Subsequent to an updated evidence report and systematic review, the US Preventive Services Task Force (USPSTF) concluded that evidence is insufficient to assess the balance of benefits and harms of screening for open-angle glaucoma in asymptomatic adults 40 years or older.[49][50]

See Prognosis for information on risk stratification.

Use of this content is subject to our disclaimer